Nabel; Elizabeth G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nabel; Elizabeth G..The latest application filed is for "methods for coating stents with dna and expression of recombinant genes from dna coated stents in vivo".

Company Profile

0.18.10

Nabel; Elizabeth G. - Washington DC
Nabel; Elizabeth G. - Ann Arbor MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
hKIS composition and methods of use Grant 7,414,035 - Nabel , et al. August 19, 2	2008-08-19
Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo App 20080112997 - Nabel; Elizabeth G. ; et al.	2008-05-15
Methods for treating cancers and restenosis with P21 App 20080095835 - Nabel; Gary J. ; et al.	2008-04-24
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor App 20070287682 - Nabel; Elizabeth G. ; et al.	2007-12-13
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor Grant 7,238,673 - Nabel , et al. July 3, 2	2007-07-03
Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor Grant 7,226,589 - Nabel , et al. June 5, 2	2007-06-05
Protein Arginine N-Methyltransferase 2 (PRMT-2) App 20060239990 - Nabel; Elizabeth G. ; et al.	2006-10-26
Methods for treating cancers and restenosis with p21 App 20060239975 - Nabel; Gary J. ; et al.	2006-10-26
Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21 Grant 7,087,582 - Nabel , et al. August 8, 2	2006-08-08
Inhibition of vascular smooth muscle cell proliferation Grant 6,979,677 - Nabel , et al. December 27, 2	2005-12-27
hKIS compositions and methods of use App 20050203050 - Nabel, Gary J. ; et al.	2005-09-15
hKIS compositions and methods of use Grant 6,894,154 - Nabel , et al. May 17, 2	2005-05-17
Method for treating proliferative diseases with p27 and fusions thereof Grant 6,884,431 - Nabel , et al. April 26, 2	2005-04-26
Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo App 20050038499 - Nabel, Elizabeth G. ; et al.	2005-02-17
Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo Grant 6,818,016 - Nabel , et al. November 16, 2	2004-11-16
Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene Grant 6,780,406 - Nabel , et al. August 24, 2	2004-08-24
hKIS compositions and methods of use Grant 6,770,473 - Nabel , et al. August 3, 2	2004-08-03
hKIS compositions and methods of use App 20040146982 - Nabel, Gary J. ; et al.	2004-07-29
Treatment Of Deseases By Site Specific Instillation Of Cells Or Sitespecific Transformation Of Cells And Kits Therefor App 20020197236 - NABEL, ELIZABETH G. ; et al.	2002-12-26
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor App 20020034505 - Nabel, Elizabeth G. ; et al.	2002-03-21
Methods for treating restenosis with p21 Grant 6,218,372 - Nabel , et al. April 17, 2	2001-04-17
Inhibition of smooth muscle cell migration by heme oxygenase I Grant 6,203,991 - Nabel , et al. March 20, 2	2001-03-20
Method for treating vascular proliferative diseases with p27 and fusions thereof Grant 6,177,272 - Nabel , et al. January 23, 2	2001-01-23
Plasmids suitable for gene therapy Grant 5,910,488 - Nabel , et al. June 8, 1	1999-06-08
Methods for treating cancers and restenosis with P21 Grant 5,863,904 - Nabel , et al. January 26, 1	1999-01-26
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor Grant 5,707,969 - Nabel , et al. January 13, 1	1998-01-13
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor Grant 5,698,531 - Nabel , et al. December 16, 1	1997-12-16
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor Grant 5,328,470 - Nabel , et al. July 12, 1	1994-07-12

Company Registrations

SEC

0001619929

NABEL ELIZABETH G

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.